Top Premarket Gainers

MT Newswires Live

Sep 29

Summit Therapeutics (SMMT) shares were up more than 23% pre-bell Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.

Navitas Semiconductor (NVTS) stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.

Q32 Bio (QTTB) shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.

Deep Fission (FISN) stock was 8.7% higher, partially reversing the 13% loss at Monday's close.

Armada Acquisition Corp. II (XRPN) shares were up over 8% after a marginal retreat at the prior close.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2671169572"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2671169572\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2671169572?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-29 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2671169572","market":"sg","top_or_hot":-1,"title":"Top Premarket Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SMMT\">Summit</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SMMT) shares were up more than 23% pre-bell Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.</p><p><a href=\"https://laohu8.com/S/NVTSW\">Navitas Semiconductor</a> (NVTS) stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.</p><p><a href=\"https://laohu8.com/S/QTTB\">Q32 Bio</a> (QTTB) shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.</p><p>Deep Fission (FISN) stock was 8.7% higher, partially reversing the 13% loss at Monday's close.</p><p>Armada Acquisition Corp. II (XRPN) shares were up over 8% after a marginal retreat at the prior close.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-29 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SMMT\">Summit</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SMMT) shares were up more than 23% pre-bell Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.</p><p><a href=\"https://laohu8.com/S/NVTSW\">Navitas Semiconductor</a> (NVTS) stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.</p><p><a href=\"https://laohu8.com/S/QTTB\">Q32 Bio</a> (QTTB) shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.</p><p>Deep Fission (FISN) stock was 8.7% higher, partially reversing the 13% loss at Monday's close.</p><p>Armada Acquisition Corp. II (XRPN) shares were up over 8% after a marginal retreat at the prior close.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4141","symbol_name":"半导体产品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2671169572","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2671169572","pubTimestamp":1790680360,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Summit Therapeutics  shares were up more than 23% pre-bell Tuesday after AstraZeneca  agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.Navitas Semiconductor  stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.Q32 Bio  shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.Deep Fission  stock was 8.7% higher, partially reversing the 13% loss at Monday's close.Armada Acquisition Corp. II  shares were up over 8% after a marginal retreat at the prior close.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4141":"半导体产品","BK4105":"独立电力生产商与能源贸易商","BK4585":"ETF&股票定投概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK4139":"生物科技","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","SMMT":"Summit Therapeutics PLC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","AZNH":"ASTRAZENECA PLC ADRhedged","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4568":"美国抗疫概念","FISN":"Deep Fission Inc","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","BK4588":"碎股","AZN":"阿斯利康","LU0058720904.USD":"联博国际健康护理基金A","XRPN":"ARMADA ACQUISITION CORP II","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","BK4007":"制药","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","NVTS":"纳微半导体","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","QTTB":"Q32 Bio Inc.","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","NVTC":"Corgi NVTS 2x Daily ETF","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","NVTX":"2倍做多NVTS ETF-Tradr"},"translate_title":"盘前涨幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XRPN":1.82,"AZNH":0.6,"FISN":1.84,"NVTS":1.92,"QTTB":1.89,"AZN":1.85,"NVTX":0.6,"NVTC":0.6,"SMMT":1.96},"content_text":"Summit Therapeutics (SMMT) shares were up more than 23% pre-bell Tuesday after AstraZeneca (AZN) agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.Navitas Semiconductor (NVTS) stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.Q32 Bio (QTTB) shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.Deep Fission (FISN) stock was 8.7% higher, partially reversing the 13% loss at Monday's close.Armada Acquisition Corp. II (XRPN) shares were up over 8% after a marginal retreat at the prior close.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}